Order results by:
Issue | Title | |
Vol 6, No 4 (2013) | Фармакоэкономический анализ использования лираглутида в составе комбинированной терапии в лечении сахарного диабета 2-го типа | Abstract similar documents |
A. Yu. Kulikov, I. V. Novikov | ||
"... ), body mass index and blood pressure are extracted. Utility values are mostly taken from the UK ..." | ||
Vol 6, No 1 (2013) | THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION | Abstract similar documents |
A. Yu. Kulikov, Yu. L. Akimova | ||
"... вакцинопрофилактики. Приведены критерии выбора показателей эффективности для различных типов вакцин, расчеты затрат на ..." | ||
Vol 6, No 4 (2013) | Pharmacoeconomical assessment of сerebrolysin in the treatment of the acute disturbances of cerebral circulation | Abstract similar documents |
A. Yu. Kulikov, L. A. Komarov | ||
"... » с использованием в качестве критерия эффективности данных о ненаступлении ин валидности терапия ..." | ||
Vol 6, No 2 (2013) | PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION | Abstract similar documents |
V. A. Chibilyaev, A. Yu. Kulikov, R. I. Yagudina | ||
"... Comparative pharmacoeconomic analysis of two therapeutic strategy (the strategy A and the strategy ..." | ||
Vol 6, No 3 (2013) | METHODOLOGICAL BASIS OF STANDARD GAMBLE METHOD USAGE IN QUALITY OF LIFE ASSESSMENT IN PHARMACOECONOMIC RESEARCHES | Abstract similar documents |
R. I. Yagudina, A. Ju. Kulikov, D. T. Ugrekhelidze | ||
"... of research using props, as well as computer programs that calculate the values of the utility automatically ..." | ||
Vol 6, No 2 (2013) | COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS | Abstract similar documents |
R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov | ||
"... использованием в качестве критериев эффективности значений достижения большого молекулярного ответа (БМО) и ..." | ||
Vol 6, No 3 (2013) | COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS | Abstract similar documents |
R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov | ||
"... эффективности, в качестве критериев эффективности были использованы значения добавленных лет жизни (LYG) и ..." | ||
1 - 7 of 7 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)